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Abstract: In vivo functionalization of diatom biosilica frustules by genetic manipulation requires
careful consideration of the overall structure and function of complex fusion proteins. Although
we previously had transformed Thalassiosira pseudonana with constructs containing a single domain
antibody (sdAb) raised against the Bacillus anthracis Sterne strain, which detected an epitope of the
surface layer protein EA1 accessible in lysed spores, we initially were unsuccessful with constructs
encoding a similar sdAb that detected an epitope of EA1 accessible in intact spores and vegetative cells.
This discrepancy limited the usefulness of the system as an environmental biosensor for B. anthracis.
We surmised that to create functional biosilica-localized biosensors with certain constructs, the biosilica
targeting and protein trafficking functions of the biosilica-targeting peptide Sil3T8 had to be uncoupled.
We found that retaining the ER trafficking sequence at the N-terminus and relocating the Sil3T8
targeting peptide to the C-terminus of the fusion protein resulted in successful detection of EA1 with
both sdAbs. Homology modeling of antigen binding by the two sdAbs supported the hypothesis
that the rescue of antigen binding in the previously dysfunctional sdAb was due to removal of steric
hindrances between the antigen binding loops and the diatom biosilica for that particular sdAb.
Keywords: diatom; biosilica; biosensor; anthrax; biotechnology; molecular biology

1. Introduction
Diatoms are a group of unicellular microalgae, often with a highly silicified, mesoporous cell
wall (frustule) exhibiting nano- to meso-scale hierarchical architecture [1–3]. Extraction of diatom
frustules can be accomplished through acid washing (e.g., [4,5]) to remove all organic components,
or by detergent extraction [6] to retain the protein complement. Acid washed diatom frustules resemble
de novo assembled mesoporous silica nanoparticles [7,8]. Whether bioinspired or diatom-derived,
these silicate structures can be chemically modified for a wide variety of uses, such as biomedical
applications [9] (e.g., cell scaffolding [10,11] and drug delivery [12,13]) or biomass conversion [14].
One attractive method for functionalizing diatom biosilica is through genetic engineering of diatoms,
whereby a biosilica-targeting protein or a derivative peptide thereof is fused to a protein of interest
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that is to be embedded into the biosilica through in vivo self-assembly. Such an approach does not
require additional chemicals for attachment, and is scalable to large growth volumes.
The diatom Thalassiosira pseudonana is a model organism for in vivo self-assembly of
genetically-modified frustules. As such, a number of proteins successfully have been used to
functionalize the biosilica frustule of this diatom species [15–18]. Recent efforts in our lab focused
on functionalization of the biosilica of T. pseudonana with chimeric fusion proteins consisting of the
diatom-derived silica targeting peptide Sil3T8 [15,16] and a small synthetic antibody derivative (e.g., a
single-chain variable fragment, scFv, or a single domain antibody, sdAb) [18,19]. Functionalization of
T. pseudonana biosilica with an sdAb against the surface layer (S-layer) protein extractable antigen 1
(EA1) of Bacillus anthracis [18] by in vivo self-assembly utilized sdAbEA1 , clone A1, which recognizes
an epitope of EA1 accessible in lysed spores [20]. Preliminary work with sdAbEA1 , clone G10, which
recognizes an epitope of EA1 that is accessible in intact vegetative cells and spores [20], produced no
functional diatom lines when targeted to the biosilica frustule. Noting that the N-terminus of the llama
VHH domain sits adjacent to the binding loops (see Figure 2 of [21], for example), we hypothesized
that our existing biosilica targeting constructs with the Sil3T8 peptide fused to the N-terminus of the
sdAbEA1 might produce a fusion protein whereby the antigen’s access to the sdAb binding loops was
occluded. For this particular protein to be functional when tethered to diatom biosilica, fusion protein
structure needed to be optimized. Our solution was to uncouple the silica targeting peptide Sil3T8
from its ER targeting sequence and locate Sil3T8 at the C-terminus of the fusion protein. After doing so,
the biosilica functionalized with sdAbEA1 clone G10—containing fusion proteins was able to bind its
target antigen EGFP-tagged EA1 protein.
2. Materials and Methods
2.1. Diatoms
Native and transformed cultures of T. pseudonana (CCMP1335; Provasoli-Guillard National
Center for Marine Algae and Microbiota, East Boothbay, ME, USA) were maintained in artificial
seawater (ESAW; https://ncma.bigelow.org/media/pdf/NCMAalgalmedium.ESAW.pdf) supplemented
with 100 µg/mL penicillin (VWR, Visalia, CA, USA) and 100 µg/mL streptomycin (Sigma-Aldrich, St.
Louis, MO, USA) under continuous illumination on an orbital shaker (~10–40 µmol/m2 /s, 20–22 ◦ C)
with gentle agitation or in a Caron (Marietta, OH, USA) plant incubator (150 µmol/m2 /s, 20 ◦ C) without
agitation. Diatoms were transformed by microparticle bombardment with a PDS-1000/He particle
delivery system as was previously described [18]. To verify integration of Gateway expression clones
into the T. pseudonana genome, PCR was performed directly on 5 µL diatom culture (1/10 volume
of PCR). Sequences of PCR primers are described in Table S1. GAPDH was used as the control
gene to verify presence of T. pseudonana DNA. Diatom biosilica frustules were isolated as previously
described for detergent extraction at 50 ◦ C with acetone rinse [6], but substituting 1% Igepal CA-630
(Sigma-Aldrich, St. Louis, MO, USA) for 1% SDS [18].
2.2. Expression Clone Construction
A diatom-specific destination vector (termed pDDV2 for Diatom Destination Vector #2) was
created by restriction cloning to contain the T. pseudonana fcp promoter [22] followed by the endoplasmic
reticulum trafficking sequence coding for the peptide MKTSAIVLLAVLATTAATEPR, the Gateway
attR1/2 integration cassette with V5 and His6 tags, and the T. pseudonana fcp terminator [22]. The
Multi-Site Gateway Pro cloning protocol was used to construct diatom-specific expression clones for
biosilica-targeted fusion proteins using either the pDDV2 (this work) or the previously created pDDV1 [18].
Plasmids containing the unmodified sdAbEA1 (either clone A1 or G10) [20] and Sil3T8 [15,16] targeting
sequences were used as templates for PCR to create entry clones for insertion into the pDDV vectors.
Detailed descriptions of all clonings are available in the Supplementary Information.
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2.3. Fluorescent Antigen Synthesis and Binding to Single Domain Antibodies
EA1-EGFP fusion protein was expressed and purified as previously described [18]. Isolated
biosilica frustules from untransformed T. pseudonana and T. pseudonana cell lines transformed with
various biosilica-targeted sdAbEA1 (either clone A1 or G10) fusion proteins were incubated with a
saturating amount of EA1-EGFP (125 nM) in PBS containing 0.05% Tween-20 (Fisher, Hampton, NJ,
USA) and 1% BSA Fraction V (Fisher, Hampton, NJ, USA) for 1 h at 4 ◦ C, followed by 1 h at room
temperature (20–25 ◦ C). Antigen-bound frustules were washed three times with PBS containing 0.05%
Tween-20 prior to imaging in the same buffer on PEI-coated coverslips. Frustule fluorescence was
examined with a Leica DM IRB inverted epifluorescence microscope equipped with a mercury metal
halide light source and liquid light guide (Leica, Wetzlar, Germany). A 460–500/505/512–542 nm filter
cube was used to collect GFP fluorescence and a 635–675/716/696–736 nm filter cube was used to verify
the absence of chlorophyll in frustule samples. Images were captured with a CoolSNAP Myo camera
(Photometrics, Tucson, AZ, USA) and Metamorph software (v.7.7.11.0; Molecular Devices, San Jose, CA,
USA). Frustules lacking detectable chlorophyll fluorescence and not overlapping any other frustules
were manually selected and their GFP-channel fluorescence intensity measured using the Metamorph
software package (v.7.7.11.0; Molecular Devices, San Jose, CA, USA).
2.4. Protein Modeling
The T. pseudonana silaffin precursor amino acid sequence (Sil3, GenBank: AAU44819.1) in FASTA
format was input into SignalP-5.0 [23,24]. Eukarya was selected as the organism group, and long
output format with figures was selected. SignalP-5.0 signal peptide prediction results are shown in
Figure S1.
Homology modeling of the structures of the sdAbs was conducted using the SWISS-MODEL
server [25]. The sdAbEA1 sequences (both clones A1 and G10) were uploaded to the ExPASy web
server, and the server searched evolutionary related protein structures against the SWISSMODEL
template library (SMTL) using two search methods: BLAST and HHblits. The templates were ranked
according to expected quality of the resulting models, as estimated by Global Model Quality Estimate
(GMQE) and Quaternary Structure Quality Estimate (QSQE). For each single domain antibody, the
top-ranked template was chosen and the homology structure was built based on that template [25–27].
For sdAbEA1 , clone G10, the top hit was 5F10 with a GMQE score of 0.78, and for sdAbEA1 , clone A1,
the top ranked template was 6GLW with a GMQE score of 0.77. The models were downloaded and the
3D protein structure visualizations and alignments were done with the open source protein structure
visualization program Pymol [28]. Since neither of the top-ranked templates was a structure with
bound antigen, we searched further in the template lists with lower GMQE scores to look for sdAb
structures with bound antigen. Two protein structures were found: a fusion protein of two domains,
Rpn8 and Rpn11, of the 26S proteasome’s deubiquitylation module bound to an sdAb (pdb bank ID
4OCN) [29] and Shiga toxin (stx2e) binding to a neutralizing sdAb (pdb bank ID 4P2C) [30] (Figure S2).
2.5. Statistical Analysis
The data were analyzed using one-way Analysis of Variance and Tukey’s HSD (honest significant
difference) posthoc test for between-group differences (significant at p ≤ 0.05). The graphical
comparisons in Figures 2 and 3 were derived from a study comparing diatoms transformed with
generation 1 and generation 2, i.e., pDDV1 and 2 pDDV2, expression vectors- and a reference group
comprising untransformed native diatoms.
3. Results
3.1. Re-Designing the Fusion Constructs
Previous reports that used Silaffin 3 (Sil3) [6] or its truncated derivative Sil3T8 [15] for in vivo
tethering of fusion proteins to T. pseudonana diatom biosilica, located the silaffin domain at the
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terminus of the protein. When tethering an sdAb to the diatom biosilica in this fashion, we
N-terminus of the protein. When tethering an sdAb to the diatom biosilica in this fashion, we
hypothesized based on structural considerations that the antigen binding loops would be oriented
hypothesized based on structural considerations that the antigen binding loops would be oriented
inward and adjacent to the biosilica rather than being exposed and facing outward away from the
inward and adjacent to the biosilica rather than being exposed and facing outward away from the
biosilica. In order to rotate the binding loops of our sdAbs away from the biosilica surface, and
biosilica. In order to rotate the binding loops of our sdAbs away from the biosilica surface, and thereby
thereby increase antigen accessibility, the Sil3T8 tether needed to become a C-terminal fusion to the
increase antigen accessibility, the Sil3T8 tether needed to become a C-terminal fusion to the sdAb. But,
sdAb. But, because the Sil3T8 peptide contains an endoplasmic reticulum (ER) trafficking sequence
because the Sil3T8 peptide contains an endoplasmic reticulum (ER) trafficking sequence [15,16], which
[15,16], which needed to remain at the N-terminus of the fusion protein sequence, simply swapping
needed to remain at the N-terminus of the fusion protein sequence, simply swapping the order of
the order of sdAbEA1 and Sil3T8 in our modular Gateway (Invitrogen) cloning system was not a feasible
sdAbEA1 and Sil3T8 in our modular Gateway (Invitrogen) cloning system was not a feasible solution.
solution. Thus, re-designing the biosilica-targeting fusion constructs for retention of the ER
Thus, re-designing the biosilica-targeting fusion constructs for retention of the ER trafficking sequence
trafficking sequence at the N-terminus of the peptide sequence was of primary concern.
at the N-terminus of the peptide sequence was of primary concern.
Two changes were made to the ER trafficking sequence in relation to our previous Sil3T8 fusion
Two changes were made to the ER trafficking sequence in relation to our previous Sil3T8 fusion
constructs: the ER trafficking sequence was (1) lengthened and (2) relocated closer to the N-terminus
constructs: the ER trafficking sequence was (1) lengthened and (2) relocated closer to the N-terminus
of the fusion protein (Figure 1b). Analysis of the T. pseudonana Sil3 peptide sequence predicted that
of the fusion protein (Figure 1b). Analysis of the T. pseudonana Sil3 peptide sequence predicted that the
the original trafficking sequence of 17 amino acids ended at the cleavage site, and that the cleavage
original trafficking sequence of 17 amino acids ended at the cleavage site, and that the cleavage site
site may be more complex than previously assumed. Therefore, we increased the length of the
may be more complex than previously assumed. Therefore, we increased the length of the trafficking
trafficking sequence to include the first 21 amino acids of the Sil3 gene. By extending this peptide
sequence to include the first 21 amino acids of the Sil3 gene. By extending this peptide sequence we
sequence we hoped to facilitate trafficking by allowing more efficient cleavage of the signal sequence.
hoped to facilitate trafficking by allowing more efficient cleavage of the signal sequence.
Further, the Gateway (Invitrogen) modular cloning system leaves substantial scars between
Further, the Gateway (Invitrogen) modular cloning system leaves substantial scars between units.
units. Our original design intended for the promoter to be one of the modular units. By leaving a scar
Our original design intended for the promoter to be one of the modular units. By leaving a scar after the
after the promoter (which also contained the start codon for the fusion protein), the ER trafficking
promoter (which also contained the start codon for the fusion protein), the ER trafficking signal began
signal began 10 amino acids downstream from the N-terminus of the protein (Figure 1b, top). In order
10 amino acids downstream from the N-terminus of the protein (Figure 1b, top). In order to continue to
to continue to employ the modular Gateway (Invitrogen) cloning of our fusion partners, and use the
employ the modular Gateway (Invitrogen) cloning of our fusion partners, and use the scars as flexible
scars as flexible linkers between fusion components, a new diatom-specific destination vector
linkers between fusion components, a new diatom-specific destination vector (pDDV2) was created
(pDDV2) was created with a static fcp promoter [22] that was immediately followed by the ER
with a static fcp promoter [22] that was immediately followed by the ER trafficking sequence. The
trafficking sequence. The Gateway (Invitrogen) scar would then be located downstream of the
Gateway (Invitrogen) scar would then be located downstream of the cleaved ER trafficking sequence
cleaved ER trafficking sequence (Figure 1b, bottom). Not only would this rearrangement of cloning
(Figure 1b, bottom). Not only would this rearrangement of cloning elements allow the ER trafficking
elements allow the ER trafficking sequence to move closer to the N-terminus of the fusion protein
sequence to move closer to the N-terminus of the fusion protein (potentially allowing more efficient
(potentially allowing more efficient recognition), but it also uncoupled the remaining 37 amino acids
recognition), but it also uncoupled the remaining 37 amino acids of the Sil3T8 biosilica targeting peptide
of the Sil3T8 biosilica targeting peptide from the trafficking sequence so that the silica targeting
from the trafficking sequence so that the silica targeting peptide could be placed on either side of its
peptide could be placed on either side of its fusion partner (Figure 1a).
fusion partner (Figure 1a).

DDV1: MHPTFLYKVAMKTSAIVLLAVLATTAA················GT
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In summary, the first generation diatom expression vector (pDDV1, Ref. [18]) was used to
In summary, the first generation diatom expression vector (pDDV1, Ref. [18]) was used to
transform T. pseudonana resulting in the in vivo self-assembly of fusion proteins having a presumably
transform T. pseudonana resulting in the in vivo self-assembly of fusion proteins having a presumably
suboptimal ER trafficking sequence (both in length and placement) and an N-terminal trafficking +
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These models help to explain our observations in relation to sdAbEA1/A1, whereby EA1-EGFP
binding is not substantially improved by our construct re-design. A side-facing binding surface
mean that sdAbEA1 /A1 binding would not be sterically hindered by a fusion partner at either terminus
would mean that sdAbEA1/A1 binding would not be sterically hindered by a fusion partner at either
of the peptide.
terminus of the peptide.
These models also supported our hypothesis that the primary reason that we did not observe
These models also supported our hypothesis that the primary reason that we did not observe
EA1 binding by our first generation Sil3T8 -sdAbEA1 /G10-functionalized diatom biosilica was due to
EA1 binding by our first generation Sil3T8-sdAbEA1/G10-functionalized diatom biosilica was due to
steric hindrance when the fusion protein was tethered to diatom biosilica by the N-terminally-located
steric hindrance when the fusion protein was tethered to diatom biosilica by the N-terminally-located
Sil3T8 silica-targeting peptide. Tethering to the diatom biosilica using the C-terminal fusion with the
Sil3T8 silica-targeting peptide. Tethering to the diatom biosilica using the C-terminal fusion with the
uncoupled Sil3T80 biosilica-targeting peptide would have alleviated some of that stress.
uncoupled Sil3T8′ biosilica-targeting peptide would have alleviated some of that stress.
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4. Discussion

Individual protein structures often dictate the order of complex fusion protein partners. Problems
4. Discussion
arise when combining peptides with incompatible fusion preferences, as was found to be the case in
Individual protein structures often dictate the order of complex fusion protein partners.
creating a series of diatom biosilica-targeted constructs encoding sdAbs against the B. anthracis S-layer
Problems arise when combining peptides with incompatible fusion preferences, as was found to be
protein EA1. In particular, both the Sil3T8 (e.g., [12,15,16,32]) and sdAbEA1 (e.g., [33,34]) peptides
the case in creating a series of diatom biosilica-targeted constructs encoding sdAbs against the B.
previously have been made only as N-terminal fusions to their partners. One reason for this order of
anthracis S-layer protein EA1. In particular, both the Sil3T8 (e.g., [12,15,16,32]) and sdAbEA1 (e.g.,
fusion partners is the requirement of many signal peptides’ proximity to the protein terminus, rather
[33,34]) peptides previously have been made only as N-terminal fusions to their partners. One reason
than just their amino acid sequence. Given our results with sdAbEA1 /A1, some flexibility likely does
for this order of fusion partners is the requirement of many signal peptides’ proximity to the protein
exist with this placement (i.e., “close” to the N-terminus is good enough).
terminus, rather than just their amino acid sequence. Given our results with sdAbEA1/A1, some
Further, the three-dimensional structure of each peptide in a chimeric protein must be considered.
flexibility likely does exist with this placement (i.e., “close” to the N-terminus is good enough).
Even though much of the sdAb structure is conserved, the structure of the binding loops by necessity
Further, the three-dimensional structure of each peptide in a chimeric protein must be
will vary by antigen and epitope recognized by the sdAb. For the two sdAbs described in this work,
considered. Even though much of the sdAb structure is conserved, the structure of the binding loops
which bind unique epitopes in the same antigen, predicted structural differences of their respective
by necessity will vary by antigen and epitope recognized by the sdAb. For the two sdAbs described
binding loops may have caused the antigen to be positioned differently in relation to the static regions
in this work, which bind unique epitopes in the same antigen, predicted structural differences of their
of the sdAb peptide, consequently altering the functionality of the sdAbs when they were tethered in
respective binding loops may have caused the antigen to be positioned differently in relation to the
diatom biosilica. This difference in binding location supports our observations whereby sdAbEA1 /G10
static regions of the sdAb peptide, consequently altering the functionality of the sdAbs when they
is more sensitive to fusion partner orientation than sdAbEA1 /A1. By uncoupling the trafficking and
were tethered in diatom biosilica. This difference in binding location supports our observations
biosilica targeting domains of the Sil3T8 peptide sequence, we have increased the flexibility of using this
whereby sdAbEA1/G10 is more sensitive to fusion partner orientation than sdAbEA1/A1. By uncoupling
particular peptide as a fusion partner for proteins that are more selective in regard to partner orientation.
the trafficking and biosilica targeting domains of the Sil3T8 peptide sequence, we have increased the
In conclusion, we note that while modular cloning systems for synthetic biology are attractive
flexibility of using this particular peptide as a fusion partner for proteins that are more selective in
due to their inherent convenience, cellular biology (e.g., protein trafficking) and biochemical (e.g.,
regard to partner orientation.
protein folding) considerations ultimately must guide the design of fusion proteins. This principle was

Biology 2020, 9, 14

8 of 9

especially relevant to the construction of functionalized diatom biosilica through genetic modification
with two related sdAbs for the detection of the pathogenic bacteria B. anthracis.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-7737/9/1/14/s1,
Supplementary Methods, Table S1: PCR primers for cloning and analysis, Table S2: PCR primers for gateway
entry clones; Table S3: Gateway entry clones, Table S4: Gateway expression clones, Figure S1: SignalP prediction
of ER trafficking sequence, Figure S2: Illustration of two single domain antibodies bound to antigen, Peptide
sequences of fusion constructs.
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